These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 783198)

  • 1. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of experimental insulin deficiency on glucagon secretion.
    Müller WA; Faloona GR; Unger RH
    J Clin Invest; 1971 Sep; 50(9):1992-9. PubMed ID: 4935445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Schneider V; Karam JH; Noacco C
    J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS; Eaton RP
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
    Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
    N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucagon in diabetes.
    Unger RH; Orci L
    Arch Intern Med; 1977 Apr; 137(4):482-91. PubMed ID: 403869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotinic acid on the plasma pancreatic glucagon, insulin and free fatty acid in diabetic subjects.
    Tasaka Y; Sekine M; Yoshida Y; Hirata Y
    Horm Metab Res; 1976 Nov; 8(6):489. PubMed ID: 1002108
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects.
    Wise JK; Hendler R; Felig P
    N Engl J Med; 1973 Mar; 288(10):487-90. PubMed ID: 4567490
    [No Abstract]   [Full Text] [Related]  

  • 14. Retardant effect of hyperglycemia on the rise in plasma fatty acids following insulin withdrawal in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabin D
    Horm Metab Res; 1981 Oct; 13(10):542-5. PubMed ID: 6117512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various disturbances in beta cell function in diabetes mellitus].
    Lohmann D; Verlohren HJ; Ellorhaoui M
    Endokrinologie; 1977 Jul; 69(2):239-45. PubMed ID: 334525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrine pancreas function in mucoviscidosis].
    Knöpfle G
    Klin Padiatr; 1985; 197(1):13-20. PubMed ID: 3883047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of insulin treatment on the metabolic response to glucagon in diabetes.
    Elkeles RS; Hambley J; Frost PG
    Diabete Metab; 1977 Mar; 3(1):35-8. PubMed ID: 192610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.